NCT04111523View on ClinicalTrials.gov

Single-dose Incremental Intravenous Injection of SY-007 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

May 26, 2020

Study Completion Date

May 26, 2020

Conditions
Cerebral Apoplexy
Interventions
DRUG

SY-007

A single dose of SY-007 or placebo injection(1mg-45mg)

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

INDUSTRY

NCT04111523 - Single-dose Incremental Intravenous Injection of SY-007 in Healthy Subjects | Biotech Hunter | Biotech Hunter